Top News

Optimer Pharmaceuticals Raises $32.9M In PIPE

San Diego-based Optimer Pharmaceuticals, a biopharmaceutical company focused on antibiotics, said Thursday that it has raised $32.9M in a registered direct offering from institutional investors. Those investors were not disclosed. The firm said it will sell 2,794,700 newly issued shares of its common stock at a purchase price of $10.00 per share. Optimer has two lead products, a antibiotic in phase 3 trials for Clostridium difficile infection, and an antibiotic for treating 'travelers' diarrhea'.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel